May 17, 2020

Traceall Global tracks new business overseas thanks to UKSE

UK SCM
product traceability
European technology
Admin
3 min
Scott Webb (regional executive at UKSE), Claire Nelson (senior vice president at Traceall Global) and Alan Steele (managing director at Traceall Global)
UK Steel Enterprise (UKSE), the Tata Steel subsidiary tasked with economic regeneration, has invested a six figure sum in high-tech tracking and monitor...

UK Steel Enterprise (UKSE), the Tata Steel subsidiary tasked with economic regeneration, has invested a six figure sum in high-tech tracking and monitoring expert Traceall Global Ltd to create new jobs and extend the company’s market reach.

Traceall Global Ltd provides companies, predominantly within the food and drink sector, with products and software designed to monitor multiple critical variables such as temperature, humidity, flow rate,  CO2, location, and impact through the supply chain using state-of-the-art sensors and sophisticated software, as well as managing detailed supplier and product information for major brands nationally.

The company has already employed three members of staff since the start of the year and is recruiting a further three this month with the intention of creating another 14 jobs by the middle of next year due to Traceall Global’s rapid growth.

The additional members of staff will include software developers, installation and support engineers, commercial and support staff and administrative support.

Famous names including The Coca Cola Company, Jamie Oliver Group and Selfridges are already using Traceall Global’s services to monitor their products and better manage their business.

Scott Webb, regional executive at UKSE said: “Traceall Global is providing unique and innovative technology and services from Scotland to some of the biggest brands around the globe.

“It is very exciting for UKSE to be investing in a company with such huge potential and an already strong market presence.

“While the company is making deals worldwide, the management team is committed to creating jobs for local people in Lanarkshire which is exactly the kind of business we are keen to support.”

Traceall Global has recently secured a seven figure contract with The Coca Cola Company to provide the drinks giant with global asset tracking and is about to embark on a major pilot project in the US with one of the world’s biggest brands.

Alan Steele, managing director at Traceall Global said: “This is a really exciting time for our business and we are looking forward to seeing where this investment takes us.

 “The investment will allow us to introduce our technology to new international markets and we have already been able to put our brand in front of companies across the Atlantic, with several new exciting business opportunities arising as a result.

“It is extremely encouraging to have UKSE’s support and the financial backing has given us a platform to promote our business and to put ourselves in front of key industry contacts.”

Traceall Global is based at UKSE’s Grovewood Business Centre, within Strathclyde Business Park, in Lanarkshire. Alan added: “UKSE’s managed workspace has given the company a real sense of identity and purpose.

 

“The space adapted well to our business requirements and having such a base has enabled us to progress as a team. And being based in Bellshill has not hindered our growth into global markets at all; in fact, it has helped the team to service our customers far more effectively”

 

UK Steel Enterprise, formerly British Steel, was the first organisation to introduce the managed workspace concept into steel areas.

 

UKSE offers office and workshop accommodation in a range of different-sized units whilst offering tenants a variety of business support services.

Share article

Jun 11, 2021

NTT DATA Services, Remodelling Supply Chains for Resilience

NTTDATA
supplychain
Supplychainriskmanagement
Procurement
6 min
Joey Dean, Managing Director of healthcare consulting at NTT DATA Services, shares remodelling strategies for more resilient supply chains

Joey Dean, the man with the coolest name ever and Managing Director in the healthcare consulting practice for NTT DATA and is focused on delivering workplace transformation and enabling the future workforce for healthcare providers. Dean also leads client innovation programs to enhance service delivery and business outcomes for clients.

The pandemic has shifted priorities and created opportunities to do things differently, and companies are now looking to build more resilient supply chains, none needed more urgently than those within the healthcare system. Dean shares with us how he feels they can get there.

A Multi-Vendor Sourcing Approach

“Healthcare systems cannot afford delays in the supply chain when there are lives at stake. Healthcare procurement teams are looking at multi-vendor sourcing strategies, stockpiling more inventory, and ways to use data and AI to have a predictive view into the future and drive greater efficiency.

“The priority should be to shore up procurement channels and re-evaluate inventory management norms, i.e. stockpiling for assurance. Health systems should take the opportunity to renegotiate with their current vendors and broaden the supplier channel. Through those efforts, work with suppliers that have greater geographic diversity and transparency around manufacturing data, process, and continuity plans,” says Dean.

But here ensues the never-ending battle of domestic vs global supply chains. As I see it, domestic sourcing limits the high-risk exposure related to offshore sourcing— Canada’s issue with importing the vaccine is a good example of that. So, of course, I had to ask, for lifesaving products, is building domestic capabilities an option that is being considered?

“Domestic supply chains are sparse or have a high dependence on overseas centres for parts and raw materials. There are measures being discussed from a legislative perspective to drive more domestic sourcing, and there will need to be a concerted effort by Western countries through a mix of investments and financial incentives,” Dean explains.

Wielding Big Tech for Better Outcomes

So, that’s a long way off. In the meantime, leveraging technology is another way to mitigate the risks that lie within global supply chains while decreasing costs and improving quality. Dean expands on the potential of blockchain and AI in the industry

“Blockchain is particularly interesting in creating more transparency and visibility across all supply chain activities. Organisations can create a decentralised record of all transactions to track assets from production to delivery or use by end-user. This increased supply chain transparency provides more visibility to both buyers and suppliers to resolve disputes and build more trusting relationships. Another benefit is that the validation of data is more efficient to prioritise time on the delivery of goods and services to reduce cost and improve quality. 

“Artificial Intelligence and Machine Learning (AI/ML) is another area where there’s incredible value in processing massive amounts of data to aggregate and normalise the data to produce proactive recommendations on actions to improve the speed and cost-efficiency of the supply chain.”

Evolving Procurement Models 

From asking more of suppliers to beefing up stocks, Dean believes procurement models should be remodelled to favour resilience, mitigate risk and ensure the needs of the customer are kept in view. 

“The bottom line is that healthcare systems are expecting more from their suppliers. While transactional approaches focused solely on price and transactions have been the norm, collaborative relationships, where the buyer and supplier establish mutual objectives and outcomes, drives a trusting and transparent relationship. Healthcare systems are also looking to multi-vendor strategies to mitigate risk, so it is imperative for suppliers to stand out and embrace evolving procurement models.

“Healthcare systems are looking at partners that can establish domestic centres for supplies to mitigate the risks of having ‘all of their eggs’ in overseas locations. Suppliers should look to perform a strategic evaluation review that includes a distribution network analysis and distribution footprint review to understand cost, service, flexibility, and risks. Included in that strategy should be a “voice of the customer” assessment to understand current pain points and needs of customers.”

“Healthcare supply chain leaders are re-evaluating the Just In Time (JIT) model with supplies delivered on a regular basis. The approach does not require an investment in infrastructure but leaves organisations open to risk of disruption. Having domestic centres and warehousing from suppliers gives healthcare systems the ability to have inventory on hand without having to invest in their own infrastructure. Also, in the spirit of transparency, having predictive views into inventory levels can help enable better decision making from both sides.”

But, again, I had to ask, what about the risks and associated costs that come with higher inventory levels, such as expired product if there isn’t fast enough turnover, tying up cash flow, warehousing and inventory management costs?

“In the current supply chain environment, it is advisable for buyers to carry an in-house inventory on a just-in-time basis, while suppliers take a just-in-case approach, preserving capacity for surges, retaining safety stock, and building rapid replenishment channels for restock. But the risk of expired product is very real. This could be curbed with better data intelligence and improved technology that could forecast surges and predictively automate future supply needs. In this way, ordering would be more data-driven and rationalised to align with anticipated surges. Further adoption of data and intelligence and will be crucial for modernised buying in the new normal.

The Challenges

These are tough tasks, so I asked Dean to speak to some of the challenges. Luckily, he’s a patient guy with a lot to say.

On managing stakeholders and ensuring alignment on priorities and objectives, Dean says, “In order for managing stakeholders to stay aligned on priorities, they’ll need more transparency and collaborative win-win business relationships in which both healthcare systems and medical device manufacturers are equally committed to each other’s success. On the healthcare side, they need to understand where parts and products are manufactured to perform more predictive data and analytics for forecasting and planning efforts. And the manufacturers should offer more data transparency which will result in better planning and forecasting to navigate the ebbs and flows and enable better decision-making by healthcare systems.

Due to the sensitive nature of the information being requested, the effort to increase visibility is typically met with a lot of reluctance and push back. Dean essentially puts the onus back on suppliers to get with the times. “Traditionally, the relationships between buyers and suppliers are transactional, based only on the transaction between the two parties: what is the supplier providing, at what cost, and for what length of time. The relationship begins and ends there. The tide is shifting, and buyers expect more from their suppliers, especially given what the pandemic exposed around the fragility of the supply chain. The suppliers that get ahead of this will not only reap the benefits of improved relationships, but they will be able to take action on insights derived from greater visibility to manage risks more effectively.”

He offers a final tip. “A first step in enabling a supply chain data exchange is to make sure partners and buyers are aware of the conditions throughout the supply chain based on real-time data to enable predictive views into delays and disruptions. With well understand data sets, both parties can respond more effectively and work together when disruptions occur.”

As for where supply chain is heading, Dean says, “Moving forward, we’ll continue to see a shift toward Robotic Process Automation (RPA), Artificial Intelligence (AI), and advanced analytics to optimise the supply chain. The pandemic, as it has done in many other industries, will accelerate the move to digital, with the benefits of improving efficiency, visibility, and error rate. AI can consume enormous amounts of data to drive real-time pattern detection and mitigate risk from global disruptive events.”

 

Share article